AIM ImmunoTech to Present at the Q1 Virtual Investor Summit on March 24th

Rhea-AI Summary

AIM ImmunoTech Inc. (NYSE American: AIM) has announced that its CEO, Thomas K. Equels, will present at the Q1 Virtual Investor Summit from March 23-25, 2021. The presentation is scheduled for March 24 at 3:00 PM ET. This summit is an independent conference bringing together smallcap companies and investors. AIM ImmunoTech focuses on developing therapeutics for various cancers, immune disorders, and viral diseases, including COVID-19. Interested parties can register for the event online.

OCALA, Fla., March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – AIM ImmunoTech Inc. (NYSE American: AIM) today announced that Thomas K. Equels, Chief Executive Officer of AIM ImmunoTech, will be presenting at the Q1 Virtual Investor Summit.

Event	Q1 Investor Summit
Date	March 23-25th, 2021
Presentation	March 24th @ 3:00 PM ET
Location	https://zoom.us/webinar/register/WN_y7LDL2ROTQqvz3iOVkINMw

About The Investor Summit
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 100 companies and over 300 institutional and retail investors. 

To request complimentary investor registration: please visit the following website at www.investorsummitgroup.com 

About AIM ImmunoTech Inc. 
AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of
therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.

Investor Relations Contact:
Crescendo Communications, LLC
Phone: 212-671-1021
Email: aim@crescendo-ir.com

AIM ImmunoTech Inc
Phone: 800-778-4042
Email: IR@aimimmuno.com

Investor Summit Contact: 
Brittney Blocker at brittney@investorsummitgroup.com

Wire Service Contact
InvestorWire (IW)
Los Angeles, California
www.InvestorWire.com
212.418.1217 Office
Editor@InvestorWire.com

 

FAQ

What event is AIM ImmunoTech participating in March 2021?

AIM ImmunoTech is participating in the Q1 Virtual Investor Summit from March 23-25, 2021.

When is AIM ImmunoTech's presentation at the Investor Summit?

AIM ImmunoTech's presentation is scheduled for March 24, 2021, at 3:00 PM ET.

How can I register for the Q1 Investor Summit?

You can register for the Q1 Investor Summit by visiting www.investorsummitgroup.com.

What is the focus of AIM ImmunoTech's research?

AIM ImmunoTech focuses on developing therapeutics for cancers, immune disorders, and viral diseases, including COVID-19.

Where can I find more information about AIM ImmunoTech's presentation?

More information about AIM ImmunoTech's presentation can be found on the Investor Summit's website and their official announcement.